Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT/JAK/MAPK pathways in streptozotocin-induced diabetic rats
Nora El-Sayed, Yasser M. Mostafa, Noha M. Abogresha, Amal A.M. Ahmed, Islam Mahmoud, Norhan M. El‐Sayed
Topics & Concepts
Diabetic cardiomyopathyMedicineStreptozotocinProtein kinase BCardioprotectionErythropoietinEndocrinologyInternal medicinePI3K/AKT/mTOR pathwayJanus kinase 2MAPK/ERK pathwayKinaseDiabetes mellitusSignal transductionCardiomyopathyIschemiaHeart failureChemistryReceptorBiochemistryCardiovascular Function and Risk FactorsDiabetes Treatment and ManagementApelin-related biomedical research